"AMR New Orleans (formerly NOCCR) performs clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines."

During the past decade, AMR New Orleans conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AMR New Orleans" #1 collaborator was "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AMR New Orleans" are "Botulinum Toxin" (1 trials), "Healthy" (1 trials), "Migraine" (1 trials) and "Pneumococcal Vaccines" (1 trials). Many other conditions were trialed in "AMR New Orleans" in a lesser frequency.

Most popular intervention types in "AMR New Orleans" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "24-Valent Pneumococcal Conjugate Vaccine" (1 trials), "BHV-3500 (zavegepant)" (1 trials), "G03-52-01" (1 trials) and "Pneumococcal 20-valent Conjugate Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "AMR New Orleans" are 3 trials for "All" genders.

Currently, there are NaN active trials in "AMR New Orleans". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AMR New Orleans, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AMR New Orleans, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".